Literature DB >> 9845293

Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.

M M Verbeek1, I Otte-Höller, R Veerhuis, D J Ruiter, R M De Waal.   

Abstract

Senile plaques and cerebrovascular amyloidosis (CA) are two of the major neuropathological lesions in brains of patients with dementia of the Alzheimer type. We studied the expression of a number of amyloid beta (A beta)-associated proteins in CA, which have previously been identified in senile plaques and which were suggested to play an important role in the pathogenesis of these lesions. Our findings show that involvement of inflammatory components in CA is restricted to activation of the complement system, resulting in deposition of the complement factors C1q, C3c, C4d and the membrane attack complex C5b-9 as well as of the complement inhibitor clusterin. Furthermore, we observed expression of apolipoprotein E, amyloid P component and heparan sulfate proteoglycans in CA, whereas expression of lactoferrin was almost absent. Other inflammatory proteins, known to be present in senile plaques, such as alpha1-antichymotrypsin, alpha2-macroglobulin and intercellular adhesion molecule-1, were absent or detectable only in small amounts. These data suggest that an incomplete inflammatory response occurs in CA as compared to senile plaques. This was confirmed by the finding that the number of cells of the monocyte/macrophage lineage around CA was not increased compared to unaffected vessels. Based on their expression patterns, complement factors, apolipoprotein E and heparan sulfate proteoglycans may be produced early in the process of CA formation and may play an important role in the formation of A beta fibrils in CA. The absence of a number of A beta-associated proteins in CA in comparison to senile plaques is in support of a different pathogenesis for these two lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845293     DOI: 10.1007/s004010050944

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

Authors:  M M Verbeek; I Otte-Höller; J van den Born; L P van den Heuvel; G David; P Wesseling; R M de Waal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models.

Authors:  Pierre De Rossi; Robert J Andrew; Timothy F Musial; Virginie Buggia-Prevot; Guilian Xu; Moorthi Ponnusamy; Han Ly; Sofia V Krause; Richard C Rice; Valentine de l'Estoile; Tess Valin; Someya Salem; Florin Despa; David R Borchelt; Vytas P Bindokas; Daniel A Nicholson; Gopal Thinakaran
Journal:  Brain Pathol       Date:  2018-12-27       Impact factor: 6.508

Review 3.  Protein homeostasis at the plasma membrane.

Authors:  Pirjo M Apaja; Gergely L Lukacs
Journal:  Physiology (Bethesda)       Date:  2014-07

4.  Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy.

Authors:  D T Winkler; L Bondolfi; M C Herzig; L Jann; M E Calhoun; K H Wiederhold; M Tolnay; M Staufenbiel; M Jucker
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

Review 5.  Complement in the brain.

Authors:  Robert Veerhuis; Henrietta M Nielsen; Andrea J Tenner
Journal:  Mol Immunol       Date:  2011-05-04       Impact factor: 4.407

6.  Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant.

Authors:  Francisco J Muñoz; Carlos Opazo; Gabriel Gil-Gómez; Gladys Tapia; Virginia Fernández; Miguel A Valverde; Nibaldo C Inestrosa
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

Review 7.  Alzheimer's silent partner: cerebral amyloid angiopathy.

Authors:  Tanya L Cupino; Matthew K Zabel
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

Review 8.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Blas Frangione; Agueda Rostagno; Jorge Ghiso
Journal:  Acta Neuropathol       Date:  2009-02-19       Impact factor: 17.088

9.  Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Douglas G Walker; Jessica E Dalsing-Hernandez; Lih-Fen Lue
Journal:  Microvasc Res       Date:  2007-11-01       Impact factor: 3.514

10.  ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.

Authors:  Alex Montañola; Sofía Fernández de Retana; Antonio López-Rueda; Cristina Merino-Zamorano; Anna Penalba; Paula Fernández-Álvarez; David Rodríguez-Luna; Ana Malagelada; Francesc Pujadas; Joan Montaner; Mar Hernández-Guillamon
Journal:  Neuromolecular Med       Date:  2015-12-14       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.